SEC Comment Letter for Invivyd, (IVVD) — Sep 30, 2022
Invivyd, Inc.
Date: Sept. 30, 2022 · CIK: 0001832038 · Accession: 0000000000-22-010798
AI Filing Summary & Sentiment
File numbers found in text: 333-267643
Letter
United States securities and exchange commission logo September 30, 2022 David Hering Chief Executive Officer Invivyd, Inc. 1601 Trapelo Road, Suite 178 Waltham, MA 02451 Re:Invivyd, Inc. Registration Statement on Form S-3 Filed September 28, 2022 File No. 333-267643 Dear Ms. Hering: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Stephen M. Nicolai, Esq.
Show Raw Text
United States securities and exchange commission logo
September 30, 2022
David Hering
Chief Executive Officer
Invivyd, Inc.
1601 Trapelo Road, Suite 178
Waltham, MA 02451
Re:Invivyd, Inc.
Registration Statement on Form S-3
Filed September 28, 2022
File No. 333-267643
Dear Ms. Hering:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Stephen M. Nicolai, Esq.